Oxidative stress and brain diseases: Biomarkers and analytical methodologies

Indian Journal of Biotechnology

Volumn 10, Issue 4, 2011, Pages 395-403

  Mancinelli, Rosanna ^a   Barlocci, Eleonora ^a   Palminiello, Sonia ^b   Saso, Luciano ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Analytical procedures; Biomarkers; Brain diseases; Oxidative stress

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYTRYPTOPHOL; ALCOHOL; CARBOHYDRATE DEFICIENT TRANSFERRIN; ETHYL GLUCURONIDE; GAMMA GLUTAMYLTRANSFERASE; HEAT SHOCK PROTEIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RETINOL BINDING PROTEIN;

ALCOHOL ABUSE; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; BRAIN DAMAGE; BRAIN DISEASE; COST BENEFIT ANALYSIS; DOWN SYNDROME; HUMAN; OXIDATIVE STRESS;

EID: 83455221329     PISSN: 09725849     EISSN: 09750967     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Das S K & Vasudevan D M, Alcohol-induced oxidative stress, Life Sci, 81 (2007) 177-87.
2. Yeum K J, Russell R M, Krinsky N I & Aldini G, Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma, Arch Biochem Biophys, 43 (2004) 97-103.
3. Zana M, Janka Z & Kálmán J, Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease, Neurobiol Aging, 28 (2007) 648-676.
4. Kohen R & Nyska A, Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification, Toxicol Pathol, 30 (2002) 620-650.
5. Mancinelli R & Ceccanti M (Eds), Teratogenic effects of alcohol: From the defence of woman health to the prevention of prenatal damage, Annali ISS (Spec Issue), 42 (2006) pp 1-68.
6. Cogswell M E, Weisberg P & Spong C, Cigarette smoking, alcohol use and adverse pregnancy outcomes: Implications for micronutrient supplementation, J Nutr, 133 (Suppl) (2003) 1722S-1731S.
7. Norberg A, Jones A W, Hahn R G & Gabrielsson J L, Role of variability in explaining ethanol pharmacokinetics: Research and forensic applications, Clin Pharmacokinet, 42 (2003) 1-31.
8. Cook J D, Biochemical markers of alcohol use in pregnant women, Clin Biochem, 36 (2003) 9-19.
9. Howard L A, Ahluwalia J S, Lin S K, Sellers E M & Tyndale R F, CYP2E1*1D regulatory polymorphism: Association with alcohol and nicotine dependence, Pharmacogenetics, 36 (2003) 321-328.
10. Lieber C S, Alcohol and the liver: Metabolism of alcohol and its role in hepatic and extrahepatic diseases, Mt Sinai J Med, 13 (2000) 84-94.
11. Macchia T, Mancinelli R, Gentili S, Ceccanti M, Devito R et al, Mitochondrial aspartate aminotransferase isoenzyme: A biochemical marker for the clinical management of alcoholics?, Clin Chim Acta, 263 (1997) 79-96.
12. Gemma S, Vichi S & Testai E, Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome, Neurosci Biobehav Rev, 31 (2007) 221-229.
13. Mancinelli R, Laviola G & Ceccanti M (Eds), Fetal alcohol spectrum disorders (FASD): From experimental biology to the quest for treatment, Neurosci Biobehav Rev (Spec Issue), 31 (2007) 165-286.
14. Burton G J & Jauniaux E, Oxidative stress, Best Pract Res Clin Obstet Gynaecol 25 (2011) 287-299.
15. Buttari B, Profumo E, Mancinelli R, Cesta Incani U, Tosti M E et al, Chronic and acute alcohol exposure prevents monocytes derived dendritic cells from differentiating and maturing, Int J Immunopathol Pharmacol, 21 (2008) 929-939.
16. Litten R Z, Bradley A M & Moss H B, Alcohol biomarkers in applied settings: Recent advances and future research opportunities, Alcohol Clin Exp Res, 34 (2010) 955-967.
17. Ceccanti M, Mancinelli R, Sasso G F, Allen J P, Binetti R et al, Erythrocyte thiamine (Th) esters: A major factor of the alcohol withdrawal syndrome or a candidate marker for alcoholism itself?, Alcohol, 40 (2005) 283-290.
18. Bearer C F, Bailey S M & Hoek J B, Advancing alcohol biomarkers research, Alcohol Clin Exp Res, 34 (2010) 941-945.
19. Peterson K, Biomarkers for alcohol use and abuse-A summary, Alcohol Res Health, 28 (2004/2005) 30-37.
20. Del Rio D, Stewart A J & Pellegrini N, A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, Nutr Metab Cardiovasc Dis, 15 (2005) 316-328.
21. Huang M C, Chen C C, Peng F C, Tang S H. & Chen C H, The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence, Prog Neuropsychopharmacol Biol Psychiatry, 33 (2009) 66-69.
22. Chen C H, Pan C H, Chen C C & Huang M C, Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity, Alcohol Clin Exp Res, 35 (2011) 1-7.
23. Mancinelli R, Giordano R, Ciprotti M, Costantini S, Senofonte O et al, Oxidative stress and protective factors (Vit B1, Zn, Se) in male and female alcoholics, Alcohol Alcohol, 42 (Suppl 1/PB1-10) (2007) i60.
24. Grotto D, Santa Maria L D, Boeira S, Valentini J, Charao M F et al, Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection, J Pharm Biomed Anal, 43 (2007) 619-624.
25. Pitel A L, Chanraud S, Sullivan E V & Pfefferbaum A, Callosal microstructural abnormalities in Alzheimer's disease and alcoholism: Same phenotype, different mechanisms, Psychiatry Res, 184 (2010) 49-56.
26. Floyd R A & Hensley K, Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases, Neurobiol Aging, 23 (2002) 795-807.
27. Wallace D C, Mitochondrial defects in neurodegenerative disease, Ment Retard Dev Disabil Res Rev, 7 (2001) 158-166.
28. Moreira P I, Honda K, Liu Q, Santos M S, Oliveira C R et al, Oxidative stress: The old enemy in Alzheimer's disease pathophysiology, Curr Alzheimer Res, 2 (2005) 403-408.
29. Nunomura A, Perry G, Pappolla M A, Friedland R P, Hirai K et al, Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome, J Neuropathol Exp Neurol, 59 (2000) 1011-1017.
30. Praticò D, Iuliano L, Amerio G, Tang L X, Rokach J et al, Down's syndrome is associated with increased 8,12-isoiPF2alpha-VI levels: Evidence for enhanced lipid peroxidation in vivo, Ann Neurol, 48 (2000) 795-798.
31. Nelson T J & Alkon D L, Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide, J Biol Chem, 280 (2005) 7377-7387.
32. Lustbader J W, Cirilli M, Lin C, Xu H W, Takuma K et al, ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease, Science, 304 (2004) 448-452.
33. Head E, Garzon-Rodriguez W, Johnson J K, Lott I T, Cotman C W et al, Oxidation of Abeta and plaque biogenesis in Alzheimer's disease and Down syndrome, Neurobiol Dis, 8 (2001) 792-806.
34. Gardiner K, Davisson M T & Crnic L S, Building protein interaction maps for Down's syndrome, Brief Funct Genomic Proteomic, 3 (2004) 142-156.
35. Herosimczyk A, Dejeans N, Sayd T, Ozgo M, Skrzypczak W F et al, Plasma proteome analysis: 2D gels and chips, J Physiol Pharmacol, 57 (Suppl 7) (2006) 81-93.
36. Roehrs M, Valentini J, Bulcão R, Moreira J C, Biesalski H et al, The plasma retinol levels as pro-oxidant/oxidant agents in haemodialysis patients, Nephrol Dial Transplant, 24 (2009) 2212-2218.
37. Szaflarska-Poplawska A, Siomek A, Czerwionka-Szaflarska M, Gackowski D, Rózalski R et al, Oxidatively damaged DNA/oxidative stress in children with celiac disease, Cancer Epidemiol Biomarkers Prev, 19 (2010) 1960-1965.
38. Kulkarni A P, Mittal S P, Devasagayam T P & Pal J K, Hsp90 mediates activation of the heme regulated eIF-2 alpha kinase during oxidative stress, Indian J Biochem Biophys, 47 (2010) 67-74.
39. Palminiello S, Kida E, Kaur K, Walus M, Wisniewski K E et al, Increased levels of carbonic anhydrase II in the developing Down syndrome brain, Brain Res, 1190 (2008) 193-205.
40. Kida E, Wierzba-Bobrowicz T, Palminiello S, Kaur K, Jarzabek K et al, Molecular chaperone alphaB-crystallin is expressed in the human fetal telencephalon at midgestation by a subset of progenitor cells, J Neuropathol Exp Neurol, 69 (2010) 745-759.